Pin1 -: A therapeutic target in Alzheimer neurodegeneration

被引:38
作者
Hamdane, M
Smet, C
Sambo, AV
Leroy, A
Wieruszeski, JM
Delobel, P
Maurage, CA
Ghestem, A
Wintjens, R
Bégard, S
Sergeant, N
Delacourte, A
Horvath, D
Landrieu, I
Lippens, G
Buée, L
机构
[1] INSERM, U422, IMPRT, F-59045 Lille, France
[2] Inst Pasteur, Inst Biol, CNRS, UMR 8525, F-59019 Lille, France
[3] Univ Paris 11, Fac Chatenay Malabry, Lab Biochim Appliquee, Paris, France
[4] CHRU, Hop R Salengro, Dept Neuropathol, Lille, France
[5] CEREP, Rueil Malmaison, France
关键词
tau proteins; NMR spectroscopy; cell cycle; phosphorylation; rotamase;
D O I
10.1385/JMN:19:3:275
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Alzheimer's disease, the peptidyl prolyl cis/trans isomerase Pin1 binds to phospho-Thr231 on Tau proteins and, hence, is found within degenerating neurons, where it is associated to the large amounts of abnormally phosphorylated Tau proteins. Conversely, Pin1 may restore the tubulin polymerization function of these hyperphosphorylated Tau. In the present work, we investigated, both at the cellular and molecular levels, the role of Pin1 in Alzheimer's disease through the study of its interactions with phosphorylated Tau proteins. We also showed that in neuronal cells, Pin1 upregulates the expression of cyclin D1. This, in turn, could facilitate the transition from quiescence to the G1 phase (re-entry in cell cycle) in a neuron and, subsequently, neuronal dedifferentiation and apoptosis. The involvement of Pin1 in the G0/G1 transition in neurons points to its function as a good target for the development of new therapeutic strategies in neurodegenerative disorders.
引用
收藏
页码:275 / 287
页数:13
相关论文
共 31 条
[1]   Tau protein isoforms, phosphorylation and role in neurodegenerative disorders [J].
Buée, L ;
Bussière, T ;
Buée-Scherrer, V ;
Delacourte, A ;
Hof, PR .
BRAIN RESEARCH REVIEWS, 2000, 33 (01) :95-130
[2]   The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease [J].
Delacourte, A ;
David, JP ;
Sergeant, N ;
Buée, L ;
Wattez, A ;
Vermersch, P ;
Ghozali, F ;
Fallet-Bianco, C ;
Pasquier, F ;
Lebert, F ;
Petit, H ;
Di Menza, C .
NEUROLOGY, 1999, 52 (06) :1158-1165
[3]  
DELOBEL P, 2002, IN PRESS J NEUROCHEM
[4]   Drug design - Discovering high-affinity ligands for proteins [J].
Hajduk, PJ ;
Meadows, RP ;
Fesik, SW .
SCIENCE, 1997, 278 (5337) :497-&
[5]   Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone [J].
Hennig, L ;
Christner, C ;
Kipping, M ;
Schelbert, B ;
Rücknagel, KP ;
Grabley, S ;
Küllertz, G ;
Fischer, G .
BIOCHEMISTRY, 1998, 37 (17) :5953-5960
[6]  
Jicha GA, 1997, J NEUROCHEM, V69, P2087
[7]   Solution structure of the single-domain prolyl cis/trans isomerase PIN1At from Arabidopsis thaliana [J].
Landrieu, I ;
Wieruszeski, JM ;
Wintjens, R ;
Inzé, D ;
Lippens, G .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 320 (02) :321-332
[8]   The Arabidopsis thaliana PIN1At gene encodes a single-domain phosphorylation-dependent peptidyl prolyl cis/trans isomerase [J].
Landrieu, I ;
De Veylder, L ;
Fruchart, JS ;
Odaert, B ;
Casteels, P ;
Portetelle, D ;
Van Montagu, M ;
Inzé, D ;
Lippens, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10577-10581
[9]   Neuronal apoptosis at the G1/S cell cycle checkpoint [J].
Liu, DX ;
Greene, LA .
CELL AND TISSUE RESEARCH, 2001, 305 (02) :217-228
[10]  
Lu KP, 1996, NATURE, V380, P544